JINGHAO MEDICAL
872925
TONGYI AEROSPACE
871642
Jiangsu Olive Sensors High-Tech
300507
4
Jing-Jin Electric Technologies
688280
5
Changhua Chemical Technology
301518
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Total investments | -95.06%161K | -95.06%161K | -87.37%726K | -90.69%1.18M | -83.44%2.07M | -73.00%3.26M | -73.00%3.26M | -46.85%5.75M | 4.11%12.65M | 6.95%12.52M |
-Equity investments | -83.38%113K | -83.38%113K | -69.57%185K | 62.93%1.18M | 188.86%2.07M | 5.92%680K | 5.92%680K | -2.72%608K | 13.32%723K | -6.14%718K |
-Net loan | --0 | --0 | --0 | --0 | --0 | --100K | --100K | --100K | ---- | ---- |
-Investments in other ventures under equity method | -98.06%48K | -98.06%48K | -89.26%541K | ---- | ---- | -78.31%2.48M | -78.31%2.48M | --5.04M | --11.93M | --11.8M |
Cash and cash equivalents | 331.31%2.14M | 331.31%2.14M | -21.77%1.41M | 15.30%3.59M | -27.02%532K | -58.99%495K | -58.99%495K | -17.42%1.8M | 30.25%3.12M | -75.50%729K |
Restricted cash and cash equivalents | 15.63%3.76M | 15.63%3.76M | 84.63%3.41M | 5.11%391K | 30.75%3.78M | 19.44%3.25M | 19.44%3.25M | -15.19%1.85M | -82.89%372K | 33.10%2.89M |
Receivables | 1.83%1.06M | 1.83%1.06M | -7.15%1.43M | 5.87%2.18M | 159.15%552K | 218.04%1.04M | 218.04%1.04M | 166.09%1.54M | 224.92%2.06M | 446.15%213K |
-Accounts receivable | 8.39%1.06M | 8.39%1.06M | -6.83%1.37M | 8.39%2.12M | 239.58%489K | 246.45%977K | 246.45%977K | 157.02%1.47M | 243.41%1.95M | 3,500.00%144K |
-Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --13K | --7K | ---- |
Prepaid assets | ---- | ---- | ---- | ---- | -95.24%12K | ---- | ---- | --0 | -13.46%135K | 106.56%252K |
Deferred policy acquisition costs | 7.92%109K | 7.92%109K | 8.70%175K | 8.60%240K | --40K | --101K | --101K | --161K | 240.00%221K | ---- |
Net PPE | 1,046.15%149K | 1,046.15%149K | 152.50%101K | 88.06%126K | 61.29%150K | -73.47%13K | -73.47%13K | -45.21%40K | -30.93%67K | -22.50%93K |
Other assets | -2.08%94K | -2.08%94K | 16.13%72K | 32.94%113K | -16.89%123K | -15.79%96K | -15.79%96K | --62K | --85K | --148K |
Total assets | -9.55%7.47M | -9.55%7.47M | -34.60%7.32M | -58.18%7.82M | -56.89%7.26M | -50.33%8.25M | -50.33%8.25M | -29.71%11.2M | 5.87%18.71M | -1.77%16.85M |
Liabilities | ||||||||||
Policy holders liabilities reserve | 8.31%991K | 8.31%991K | 8.41%1.59M | 8.35%2.18M | -65.89%366K | -14.73%915K | -14.73%915K | --1.46M | 240.61%2.01M | 666.43%1.07M |
Payables | 13.72%1.73M | 13.72%1.73M | ---- | ---- | ---- | 418.03%1.52M | 418.03%1.52M | ---- | ---- | ---- |
-Due to related parties | 13.72%1.73M | 13.72%1.73M | ---- | ---- | ---- | --1.52M | --1.52M | ---- | ---- | ---- |
Long term debt and capital lease obligation | 109.45%266K | 109.45%266K | 1,013.07%1.7M | 732.02%1.48M | 749.81%2.18M | -51.15%127K | -51.15%127K | -45.94%153K | -41.83%178K | -21.88%257K |
-Long term debt | 0.00%118K | 0.00%118K | 1,258.47%1.6M | 1,050.00%1.36M | 1,083.72%2.04M | -45.37%118K | -45.37%118K | -45.37%118K | -45.37%118K | -20.37%172K |
-Long term capital lease obligation | 1,544.44%148K | 1,544.44%148K | 185.71%100K | 106.67%124K | 74.12%148K | -79.55%9K | -79.55%9K | -47.76%35K | -33.33%60K | -24.78%85K |
Other liabilities | 2.81%366K | 2.81%366K | -76.55%383K | -72.54%374K | -35.74%214K | --356K | --356K | --1.63M | --1.36M | --333K |
Total liabilities | 14.86%3.36M | 14.86%3.36M | 13.02%3.67M | 13.59%4.04M | 66.21%2.76M | 79.53%2.92M | 79.53%2.92M | 97.03%3.25M | 180.65%3.55M | 94.28%1.66M |
Shareholders'equity | ||||||||||
Share capital | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K |
-common stock | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K |
Paid-in capital | 4.17%34.11M | 4.17%34.11M | 1.96%33.33M | 1.01%32.92M | 0.85%32.81M | 0.79%32.74M | 0.79%32.74M | 0.72%32.68M | 0.50%32.59M | 0.46%32.54M |
Retained earnings | -10.03%-30.16M | -10.03%-30.16M | -19.96%-29.68M | -67.07%-29.14M | -63.16%-28.32M | -56.66%-27.41M | -56.66%-27.41M | -36.12%-24.74M | -8.81%-17.44M | -7.83%-17.36M |
Total stockholders'equity | -25.96%3.95M | -25.96%3.95M | -54.06%3.65M | -75.01%3.79M | -70.37%4.5M | -64.43%5.33M | -64.43%5.33M | -44.34%7.95M | -7.62%15.16M | -6.82%15.19M |
Noncontrolling interests | --162K | --162K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Total equity | -22.92%4.11M | -22.92%4.11M | -54.06%3.65M | -75.01%3.79M | -70.37%4.5M | -64.43%5.33M | -64.43%5.33M | -44.34%7.95M | -7.62%15.16M | -6.82%15.19M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |